Yeon Kyung Choi

Title: Yeon Kyung Choi: Innovator in Anticancer Pharmaceutical Composition

Introduction

Yeon Kyung Choi is a notable inventor based in Daegu, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions aimed at enhancing anticancer effects. His work is particularly relevant in the context of liver cancer treatment.

Latest Patents

Yeon Kyung Choi holds 1 patent for his invention titled "Use of composition for enhancing anticancer effect, comprising ERRγ inhibitor as active ingredient." This innovative pharmaceutical composition is designed to inhibit the resistance of liver cancer to sorafenib, a common treatment, thereby enhancing its anticancer effect. The active ingredient in this composition is an Estrogen-related receptor γ (ERRγ) inhibitor, which has shown promise in treating sorafenib-resistant advanced liver cancer.

Career Highlights

Choi is currently associated with Novmetapharma Co., Ltd., where he continues to advance his research and development efforts in the pharmaceutical industry. His work is characterized by a commitment to improving treatment options for patients facing challenging medical conditions.

Collaborations

Some of his notable coworkers include Keun Gyu Park and Jung Wook Chin, who contribute to the collaborative efforts in research and development at Novmetapharma Co., Ltd.

Conclusion

Yeon Kyung Choi's innovative work in the field of anticancer pharmaceuticals highlights the importance of research in developing effective treatments for resistant forms of cancer. His contributions are paving the way for advancements in cancer therapy.